TY - JOUR
T1 - Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
AU - Kaidanovich-Beilin, Oksana
AU - Lipina, Tatiana V.
AU - Takao, Keizo
AU - Van Eede, Matthijs
AU - Hattori, Satoko
AU - Laliberté, Christine
AU - Khan, Mustafa
AU - Okamoto, Kenichi
AU - Chambers, John W.
AU - Fletcher, Paul J.
AU - MacAulay, Katrina
AU - Doble, Bradley W.
AU - Henkelman, Mark
AU - Miyakawa, Tsuyoshi
AU - Roder, John
AU - Woodgett, James R.
N1 - Funding Information:
We appreciate the support of Igor Vukobradovic (for instructions to rotorod test); Dr. Holy Bates (for design of corticosteroid experiments); Dr. Vera Eremina (for IHC technical support). This work was supported by CIHR grant MOP 74711 to JRW and by KAKENHI (Grant-in-Aid for Scientific Research) on Integrative Brain Research (IBR-shien) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to TM. Portions of this work were presented in the poster section (881.11) of SfN08 conference, Washington.
PY - 2009
Y1 - 2009
N2 - Background. Glycogen synthase kinase-3 (GSK-3) is a widely expressed and highly conserved serine/threonine protein kinase encoded by two genes that generate two related proteins: GSK-3 and GSK-3. Mice lacking a functional GSK-3 gene were engineered in our laboratory; they are viable and display insulin sensitivity. In this study, we have characterized brain functions of GSK-3 KO mice by using a well-established battery of behavioral tests together with neurochemical and neuroanatomical analysis. Results. Similar to the previously described behaviours of GSK-3+/-mice, GSK-3 mutants display decreased exploratory activity, decreased immobility time and reduced aggressive behavior. However, genetic inactivation of the GSK-3 gene was associated with: decreased locomotion and impaired motor coordination, increased grooming activity, loss of social motivation and novelty; enhanced sensorimotor gating and impaired associated memory and coordination. GSK-3 KO mice exhibited a deficit in fear conditioning, however memory formation as assessed by a passive avoidance test was normal, suggesting that the animals are sensitized for active avoidance of a highly aversive stimulus in the fear-conditioning paradigm. Changes in cerebellar structure and function were observed in mutant mice along with a significant decrease of the number and size of Purkinje cells. Conclusion. Taken together, these data support a role for the GSK-3 gene in CNS functioning and possible involvement in the development of psychiatric disorders.
AB - Background. Glycogen synthase kinase-3 (GSK-3) is a widely expressed and highly conserved serine/threonine protein kinase encoded by two genes that generate two related proteins: GSK-3 and GSK-3. Mice lacking a functional GSK-3 gene were engineered in our laboratory; they are viable and display insulin sensitivity. In this study, we have characterized brain functions of GSK-3 KO mice by using a well-established battery of behavioral tests together with neurochemical and neuroanatomical analysis. Results. Similar to the previously described behaviours of GSK-3+/-mice, GSK-3 mutants display decreased exploratory activity, decreased immobility time and reduced aggressive behavior. However, genetic inactivation of the GSK-3 gene was associated with: decreased locomotion and impaired motor coordination, increased grooming activity, loss of social motivation and novelty; enhanced sensorimotor gating and impaired associated memory and coordination. GSK-3 KO mice exhibited a deficit in fear conditioning, however memory formation as assessed by a passive avoidance test was normal, suggesting that the animals are sensitized for active avoidance of a highly aversive stimulus in the fear-conditioning paradigm. Changes in cerebellar structure and function were observed in mutant mice along with a significant decrease of the number and size of Purkinje cells. Conclusion. Taken together, these data support a role for the GSK-3 gene in CNS functioning and possible involvement in the development of psychiatric disorders.
UR - http://www.scopus.com/inward/record.url?scp=72449146342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=72449146342&partnerID=8YFLogxK
U2 - 10.1186/1756-6606-2-35
DO - 10.1186/1756-6606-2-35
M3 - Article
C2 - 19925672
AN - SCOPUS:72449146342
SN - 1756-6606
VL - 2
JO - Molecular brain
JF - Molecular brain
IS - 1
M1 - 35
ER -